Picture this: Five years ago, Boston Scientific $BSX stock traded near $38 per share. Today in March 2026, it closes at $69.48 — a solid +82% gain. The chart shows a clear upward trend with some healthy pullbacks, reflecting strong demand for medical devices and procedures.

The 52-week high reached $109.50, showing the stock has already climbed significantly higher in strong periods.

Keeping it simple: The compound annual growth rate (CAGR) over these five years is about 12.7%. If this pace continues, it points to dependable yearly growth that builds steadily over time.

Now imagine using dollar-cost averaging (DCA): adding $500 every month for the next five years. This adds up to $30,000 total from your pocket over 60 months. You buy more shares when prices are lower and fewer when they rise, which helps smooth your average cost.

Build your portfolio, one day at a time.
Get our daily 5-year horizon picks sent to your inbox. Subscribe here.

If BSX follows a similar historical pace around 12.7% annual growth, your regular $500 contributions could grow your investment to about $40,850 by the end of five years. That means a gain of roughly $10,850 beyond what you put in — a solid 36% overall return from consistent investing.

Past results don't guarantee the future — healthcare trends and competition can shift outcomes. But BSX remains a leader in medical devices with good momentum in key areas. Your $500 monthly plan stays easy to manage, letting time and compounding work quietly.

The growing need for advanced medical solutions keeps supporting this sector long-term. Staying disciplined is what usually leads to good results over time.

Ready to build with this approach?